Establishing a Trigger Tool Based on Global Trigger Tools to Identify Adverse Drug Events in Obstetric Inpatients in China

Author:

Wu Shan1,Yin Qinan2,Wu Yue2,Yu Nan3,Yan Junfeng2,Bian Yuan2

Affiliation:

1. Maternal and Child Health Hospital of Shuangliu District

2. Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital /Affiliated Hospital of University of Electronic Science and Technology of China

3. Chengdu First People’s Hospital

Abstract

Abstract Background To examine the performance of an obstetric trigger tool, compared with the spontaneous reporting system (SRS) and global trigger tools (GTTs), in detecting adverse drug events (ADEs) experienced by obstetric units, and to assess the utility and value of the obstetric trigger tool in identifying ADEs of obstetric inpatients. Methods Our obstetric triggers were established on the basis of a literature review, retrospective obstetric ADE investigations, trigger extraction and revision, and expert investigations. We conducted a retrospective study to identity ADEs in 300 obstetric inpatient records at the Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital from June 1 to September 30, 2018. Results Through two rounds of expert investigation, we established 39 preliminary triggers that comprised four modules (12 laboratory tests, nine medications, 14 symptoms, and four outcomes). Three hundred medical records were reviewed by using the obstetric triggers with 49 cases of ADE detected, and the incidence of ADE was 16.33%. Among the 39 obstetric triggers, 22 triggers were positive (56.41%) and 11 of them detected ADE. The positive predictive value (PPV) was 36.36%, and the number of ADEs/100 patients was 16.33 (95% CI, 4.19–17.81). The ADE detection rate, positive trigger rate, and PPV value for the obstetric triggers were significantly augmented, confirming that the obstetric triggers were more specific and sensitive than SRS and GTT. Conclusion The obstetric triggers were proven to be sensitive and specific in the active monitoring of ADE for obstetric inpatients, and this could constitute a reference for ADE detection of obstetric inpatients at medical institutions.

Publisher

Research Square Platform LLC

Reference53 articles.

1. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group;Bates DW;JAMA,1995

2. Identifying drug safety issues: from research to practice;Gandhi TK;Int J Qual Health Care,2000

3. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies;Lazarou J;JAMA,1998

4. Classen DC, Resar R, Griffin F, et al. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured [published correction appears in Health Aff (Millwood). 2011 Jun; 30(6): 1217]. Health Aff (Millwood). 2011;30(4):581–589.

5. FDA. Pharmacovigilance planning(PvP). Geneva; 2003.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3